ELECSYS TSH ASSAY
Report
- Report Number
- 1823260-2016-01577
- Event Type
- Malfunction
- Date Received
- October 17, 2016
- Date of Event
- September 27, 2016
- Report Date
- November 11, 2016
- Manufacturer
- ROCHE DIAGNOSTICS
- Product Code
- JLW
- PMA / PMN Number
- K961491
- Removal / Correction Number
- NA
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- GM
- Reporter Occupation
- OTHER
Narratives
(B)(4). THIS EVENT OCCURRED IN (B)(6). (B)(6).
FURTHER INVESTIGATION OF THE SAMPLE DID NOT DETERMINE A SPECIFIC ROOT CAUSE FOR THE ISSUE. NO INTERFERING FACTORS WERE FOUND THAT AFFECTED THE TSH VALUE.
THE CUSTOMER RECEIVED QUESTIONABLE THYROID RESULTS FOR ONE PATIENT WHICH DID NOT FIT THE CLINICAL STATUS OF THE PATIENT AND ALLEGED THERE WERE PATIENT-SPECIFIC INTERFERING FACTORS. THE CUSTOMER USED COBAS E602 SERIAL NUMBER (B)(4). REFER TO THE ATTACHMENT TO THE MEDWATCH FOR ALL PATIENT DATA. OF THE DATA PROVIDED, ONLY THE RESULTS FOR THE ELECSYS TSH ASSAY, ANTI-TPO, AND ANTI-TSHR ASSAYS WERE A REPORTABLE MALFUNCTION. REFER TO THE MEDWATCH WITH PATIENT IDENTIFIERS (B)(6) FOR THE OTHER ASSAYS INVOLVED IN THE COMPLAINT. THE RESULTS WERE REPORTED OUTSIDE THE LABORATORY AND THE PHYSICIAN DID NOT BELIEVE THE RESULTS. DUE TO THE ELEVATED TSH, FT4 AND FT3 RESULTS, THE DOCTOR ASSUMED A PITUITARY GLAND ISSUE WHICH HAS NOT YET BEEN ANALYZED OR OFFICIALLY DIAGNOSED. THE PATIENT WAS NOT ADVERSELY AFFECTED. SAMPLE DRAWN FROM THE PATIENT ON (B)(6) 2016 WAS SUBMITTED FOR INVESTIGATION AND AN INTERFERING FACTOR TO STREPTAVIDIN WAS FOUND IN THE SAMPLE. THIS INTERFERING FACTOR CAUSED THE DIFFERENT VALUES FOR THE FT4 AND FT3 ASSAYS AND IS DOCUMENTED IN PRODUCT LABELING. REVIEW OF THE PROVIDED CALIBRATION AND QC RESULTS DID NOT INDICATE A REAGENT ISSUE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 686724 | ELECSYS TSH ASSAY | RADIOIMMUNOASSAY, THYROID-STIMULATING HORMONE | JLW | ROCHE DIAGNOSTICS | NA | 17901000 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 |